Newly Diagnosed Multiple Myeloma Completed Phase 3 Trials for Acetylsalicylic acid (DB00945)

IndicationStatusPhase
DBCOND0036257 (Newly Diagnosed Multiple Myeloma)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00405756A Study to Compare MPR With MP in Newly Diagnosed Multiple Myeloma Subjects 65 Years Old or Older.Treatment